Molecular Templates Statistics
Share Statistics
Molecular Templates has 6.58M shares outstanding. The number of shares has increased by 22.51% in one year.
| Shares Outstanding | 6.58M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 4.52M |
| Failed to Deliver (FTD) Shares | 34.38K |
| FTD / Avg. Volume | 0.22% |
Short Selling Information
The latest short interest is 297.95K, so 4.53% of the outstanding shares have been sold short.
| Short Interest | 297.95K |
| Short % of Shares Out | 4.53% |
| Short % of Float | 6.59% |
| Short Ratio (days to cover) | 0.01 |
Valuation Ratios
The PE ratio is -2.07 and the forward PE ratio is -0.14.
| PE Ratio | -2.07 |
| Forward PE | -0.14 |
| PS Ratio | 0.29 |
| Forward PS | 0 |
| PB Ratio | 3.99 |
| P/FCF Ratio | -0.4 |
| PEG Ratio | n/a |
Enterprise Valuation
Molecular Templates Inc. has an Enterprise Value (EV) of 17.50M.
| EV / Earnings | -2.15 |
| EV / Sales | 0.31 |
| EV / EBITDA | 12.24 |
| EV / EBIT | -1.67 |
| EV / FCF | -0.42 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 0.
| Current Ratio | 0.97 |
| Quick Ratio | 0.97 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -3.94 |
Financial Efficiency
Return on equity (ROE) is -1.93% and return on capital (ROIC) is -63.57%.
| Return on Equity (ROE) | -1.93% |
| Return on Assets (ROA) | -0.23% |
| Return on Capital (ROIC) | -63.57% |
| Revenue Per Employee | 924.29K |
| Profits Per Employee | -131.03K |
| Employee Count | 62 |
| Asset Turnover | 1.62 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -11.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -99.13% in the last 52 weeks. The beta is 1.22, so Molecular Templates 's price volatility has been higher than the market average.
| Beta | 1.22 |
| 52-Week Price Change | -99.13% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 23.93 |
| Average Volume (20 Days) | 15.35M |
Income Statement
In the last 12 months, Molecular Templates had revenue of 57.31M and earned -8.12M in profits. Earnings per share was -1.8.
| Revenue | 57.31M |
| Gross Profit | 50.40M |
| Operating Income | -10.47M |
| Net Income | -8.12M |
| EBITDA | 1.43M |
| EBIT | -10.47M |
| Earnings Per Share (EPS) | -1.8 |
Balance Sheet
The company has 11.52M in cash and 12.23M in debt, giving a net cash position of -707.00K.
| Cash & Cash Equivalents | 11.52M |
| Total Debt | 12.23M |
| Net Cash | -707.00K |
| Retained Earnings | -452.89M |
| Total Assets | 26.70M |
| Working Capital | 4.34M |
Cash Flow
In the last 12 months, operating cash flow was -41.82M and capital expenditures -200.00K, giving a free cash flow of -42.02M.
| Operating Cash Flow | -41.82M |
| Capital Expenditures | -200.00K |
| Free Cash Flow | -42.02M |
| FCF Per Share | -9.34 |
Margins
Gross margin is 87.94%, with operating and profit margins of -18.26% and -14.18%.
| Gross Margin | 87.94% |
| Operating Margin | -18.26% |
| Pretax Margin | -14.2% |
| Profit Margin | -14.18% |
| EBITDA Margin | 2.5% |
| EBIT Margin | -18.26% |
| FCF Margin | -73.33% |
Dividends & Yields
MTEM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -6000% |
| FCF Yield | -21063.5% |
Analyst Forecast
Currently there are no analyst rating for MTEM.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 14, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | Aug 14, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -24.97 |
| Piotroski F-Score | 2 |